Medical Research
Adenoid Cystic Carcinoma Researchfoundation
NEEDHAM, MA
Total revenue
$1.1M
Total expenses
$1.5M
Net assets
$2.2M
Grants received
$2.7M
56 grants
EIN
206745475
Tax year
2024
Mission
Supporting research into the treatment and cure of adenoid cystic carcinoma.
Programs
1 program
Basic research: accrf supports and coordinates the descriptive and functional studies that identify molecular targets and pathways that permit adenoid cystic carcinoma to progress. By focusing on the mechanisms of action, researchers may discover more quickly the achilles' heel of the disease.
Financials
FY 2024
Revenue
Expenses
People
9 listed
JEFFREY A KAUFMAN
EXECUTIVE DIRECTOR/BOARD C
$150K
50 hrs/wk
RALPH MOLLIS
TREASURER
—
5 hrs/wk
MARNIE A KAUFMAN
DIRECTOR & CFO
—
35 hrs/wk
ELIZABETH WEHLAGE
DIRECTOR
—
5 hrs/wk
DAVID MORSE
DIRECTOR
—
5 hrs/wk
BOZHO TODORICH
DIRECTOR
—
5 hrs/wk
EMMA KINLOCH
DIRECTOR
—
5 hrs/wk
THOMAS DILENGE
BOARD VICE CHAIR
—
5 hrs/wk
NICOLE SPARDY BURR
DIRECTOR OF RESEARCH
$143K
40 hrs/wk
Grants received
Showing 56 of 56
Funded by
$2.7M from 19 funders · 56 grants · 2017–2024
$999K · 8 grants · 2017–2023
$800K · 3 grants · 2017–2023
$269K · 4 grants · 2020–2024
$148K · 7 grants · 2017–2023
$131K · 6 grants · 2019–2024
$102K · 3 grants · 2018–2021
$68K · 1 grant · 2020
$61K · 3 grants · 2021–2024